 |
|
|
|
Browse alphabetically for topics addressed in
medical policies:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Introduction | Table of Contents | Recent Updates | Contact Medical Policy Staff
Index
Last updated: (May 1, 2024)
I |
|
| IDH1 and IDH2 testing |
| IDH1 and IDH2 testing (panels) |
| Idiopathic pulmonary artery hypertension |
| IFUSE® Implant System (SI Bone) |
| IgA food panel test |
| IgE in vitro
test |
| IgG allergen
levels |
| IgG4
antibody testing |
| IKBKAP |
| i-LIMB |
| Image-Guided Minimally Invasive Spinal Decompression (IG-MSD) |
| Immunotherapy; adoptive |
| Immunotherapy; sublingual |
| Impella |
| Implant;
breast |
| Implantable interstitial glucose sensor; insertion |
| Implantable interstitial glucose sensor; removal |
| Implantable magnetic esophageal ring |
IMRT |
| Incontinence,
urge, sacral nerve stimulation |
| Indego® (Parker Hannifin Corp.) |
| Inert
gas rebreathing |
| Inferential electrical stimulation |
| INFINITI® Neural Response Panel (PersonalizeDx Labs) |
| Infliximab |
| InformaSeqSM Prenatal Test (Integrated Genetics) |
| Inherited cardiomyopathy |
| Innocur |
| Innotest® assays for T-tau, P-tau, and AB-42 (Fujirebio [previously Innogenetics]) |
| Inpatient rehabilitation |
| Inpatient Behavioral Health |
| Inpatient Chemical Dependency |
| Inpatient Level of Care |
| Insight TNBCtype™ (Insight Molecular Labs) |
| In-Space (Synthes) |
| Inspan™ Spinous Process Plate System |
| Inspire® II Upper Airway Stimulation System (Inspire Medical Systems) |
| Instrateck |
| Integrated BRACAnalysis® (Myriad Genetics) |
Intensity
Modulated Radiation Therapy |
| Intensity-Modulated Radiation Therapy |
| Intensive Outpatient Program Level of Care |
| InterBRIDGE™ Interspinous Posterior Fixation System (LDR Spine) |
| Interceptor™
PLUS carotid filter system |
| Interlaminar stabilization |
| Intermediate care facility |
| Interspinous process decompression |
| Interspinous spacer |
| Interspinous anchors |
| Interspinous U (Paradigm Spine) |
| Interstim
Device |
| Intertrochanteric
osteotomy; impingement |
| Intestinal transplant |
| Intra-aortic balloon pump |
| Intracardiac ischemia monitoring |
| Intracoronary hyperoxemic perfusion |
| Intracutaneous
test |
| Intradermal
dilutional test |
| Intradermal
test |
| Intrinsic Hepcidin IDx™ Test |
| Investigational Device Exemption (IDE) |
| InVitae Assay (InVitae Corp., San Francisco, CA) |
| iPED® |
| IRF |
| Iridology,
allergy testing |
| Iris prosthesis, CustomFlex Artificial Iris |
| Irradiation;
charged particle (Proton or Helium Ion) |
| Irreversible electroporation (IRE) tumor ablation, NanoKnife (AngioDynamics) |
| Ischemic
heart disease; stem cell therapy |
| Islet autotransplantation (IAT) |
| Islet
cell transplantation |
| Isobar® (Scient’x) |
| Isolated small bowel transplantation |
| iTind |
| Ixmyelocel-T (Vericel Corporation, formerly Aastrom Biosciences) |
Comments from physicians and other health care practitioners regarding Asuris Medicare medical policies are welcome. If you are a physician and have a question or comment regarding a medical policy, please contact the medical policy staff through our secure form.
|
|
|
